Sanofi Settles Insulin Suit with Rivals Lilly, BI

Sanofi has settled a lawsuit over patents for Lantus SoloStar, its once-daily insulin in an injector-device, allowing partners Eli Lilly and Boehringer Ingelheim to sell their version in the U.S. starting December 2016.
Source: PharmaManufacturing.com - Category: Pharmaceuticals Source Type: news